EUVIMED · CrossrefZeitschrift
European Urology Open Science
ISSN 2666-1683 · Elsevier BV
Neueste Artikel
Can We Omit Systematic Biopsies in Men with a Positive MRI During Repeat Biopsies for Active Surveillance for Prostate Cancer? Results from the PRIAS Study
Primary Versus Delayed Ureteroscopy for Obstructing Ureteric Calculi: A Systematic Review and Meta-analysis from the European Association of Urology Endourology
Rapid Clearance of microRNA-371a-3p: A Longitudinal Study of Serum Levels in Patients with Localized Testicular Germ Cell Tumors
Re: Yuxi Liu, Zhengqin Xiao, Hairong He, et al. Development of the Short Form of the Specific Module of QLICD-BPH (V2.0) for Assessing Quality of Life with Benign Prostatic Hyperplasia by Classical Test Theory, Item Response Theory, and Generalizability Theory. Eur Urol Open Sci 2026;91:32–40
HoLEP Versus Mini-HoLEP: A Long-term Follow-up Prospective Randomized Controlled Trial
4Kscore as a Pre-MRI Reflex Test for Men with PSA 1.80–2.99 ng/ml in the Göteborg-2 Prostate Cancer Screening Trial
Re: Can Aydogdu, Benso John, Clara Seizer, et al. Oncologic Outcomes in a Contemporary “PROTEUS-like” Cohort of High-risk Prostate Cancer Treated with Radical Prostatectomy Without Neoadjuvant Hormonal Therapy. Eur Urol Open Sci 2026;92:10–8.
Development and External Validation of an Updated Nomogram Including Both MRI and Local PSMA PET/CT Information for the Prediction of Side-specific Extraprostatic Extension in Patients Treated with Radical Prostatectomy
Oligoprogressive Renal Cell Carcinoma Treated with Stereotactic Body Radiation Therapy Versus Switching to a New Systemic Therapy
Ex Vivo Microtumor Testing to Predict Chemotherapy Responses in Patients with Bladder Cancer
Incisional Hernia After Minimally Invasive Radical Prostatectomy: A Systematic Review
Re: Nielsen N.K, Hjort P.B, Hansen E.B, et al. Substaging and stratified treatment of T1 bladder cancer – a nationwide register‑based study. Eur Urol Open Sci 2026;90:92‑100
Reply to Drs. Bayraktar and İşler's Letter to the Editor re: Basadonna LM, Passarelli F, Graps G, et al. Music During Transperineal Prostate Biopsy (The VIVALDI Trial): A Few Questions on the Gap Between Self-reported Benefit and Objective Findings
PRECISE Assessment of Sequential Biparametric MRI and Clinically Significant Prostate Cancer in Biopsy-naive Men: A Retrospective Cohort Study
PSMA PET/CT Kinetics During Systemic Therapy and Radiotherapy in Hormone-sensitive Prostate Cancer: A Systematic Review
Global Direct In-scope Suction Study: An EAU-endourology Multicenter Prospective Collaboration (DISS-study)
Expression of NECTIN-4 and TROP-2 in Resected Upper Tract Urothelial Carcinoma with and Without Preoperative Chemotherapy
Reply to Xin Li and Yapeng Xing's Letter to the Editor re: Nielsen N.K, Hjort P.B, Hansen E.B, et al. Substaging and stratified treatment of T1 bladder cancer – a nationwide register-based study. Eur Urol Open Sci 2026;90:92-100
Editorial Board
Contents
Copyright page
Multiparametric MRI (mpMRI) bladder in muscle invasive bladder cancer (MIBC): Primetime to shorten bladder cancer pathway
PSMA-PET miN1M0 versus conventional imaging cN0M0 high-risk prostate cancer patients undergoing radical prostatectomy: A European Association of Urology-Young Academic Urologists Prostate Cancer Working Group multi-institutional study
Perirenal shell morphology separates renal pelvis upper tract urothelial carcinoma from renal cell carcinoma beyond tumour size alone
Evaluation of global prostate MRI quality – a 5-year follow-up (The GLIMPSE 2 Study)
Real-world adherence to EAU Guidelines and imaging modality discordance in prostate cancer: Interim results from the RING registry
Evaluation of 68Gallium FAPI PET/CT in patients with testicular cancer
Redefining the Phoenix criteria for biochemical recurrent prostate cancer after radiotherapy: A new PSA rise threshold in the PSMA PET/CT era
Enzalutamide plus radium-223 vs enzalutamide alone in metastatic castration-resistant prostate cancer: 4-year OS analysis and PFS-2 of the EORTC-1333/PEACE-3 trial
Contralateral nodal status predicts occult metastasis and sentinel node biopsy failure in the clinically node-negative groin
EUVIMED